Supplementary Table S1: Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 1. Atogepant and Sumatriptan: No Clinically Relevant Drug-Drug Interactions in a Randomized, Open-label, Crossover Trial Intervention Sequences
创建时间：
2021-12-13
